| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Breast Surgery, Roswell Park Cancer Institute, Buffalo, New York 14263 [C. I., C. H., R. M. B.], and Department of Nutritional Sciences, University of Wisconsin, Madison, Wisconsin 53706 [H. E. G.]
Methylated selenides are prominent metabolites at the dietary levels used for obtaining anticarcinogenic effects with selenium. The present study reports the chemopreventive activities of 2 novel selenium compounds, Se-methylselenocysteine and dimethyl selenoxide, in the rat dimethylbenz(a)anthracene-induced mammary tumor model. Other treatment groups were supplemented with either selenite or selenocystine for comparative purposes. Each selenium compound was tested at different levels and was given to the animal starting 1 week before dimethylbenz(a)anthracene administration and continued until sacrifice. Results of the carcinogenesis experiments showed that the relative efficacy with the four compounds was Se-methylselenocysteine > selenite > selenocystine > dimethyl selenoxide. In correlating the chemical form and metabolism of these selenium compounds with their anticarcinogenic activity, it is concluded that: (a) selenium compounds that are able to generate a steady stream of methylated metabolites, particularly the monomethylated species, are likely to have good chemopreventive potential; (b) anticarcinogenic activity is lower for selenoamino acids, such as selenocysteine following conversion from selenocystine, which have an escape mechanism via random, nonstoichiometric incorporation into proteins; and (c) forms of selenium, as exemplified by dimethyl selenoxide, which are metabolized rapidly and quantitatively to dimethyl selenide and trimethylselenonium and excreted, are likely to be poor choices. We also undertook a separate bioavailability study using Se-methylselenocysteine, dimethyl selenoxide, and trimethylselenonium as the staring compounds for delivering selenium with one, two, or three methyl groups, and measured the ability of these compounds to restore glutathione peroxidase activity in selenium-depleted animals. All three compounds were able to fully replete this enzyme, although with a wide range of efficiency (Se-methylselenocysteine > dimethyl selenoxide > trimethylselenonium), suggesting that complete demethylation to inorganic selenium is a normal process of selenium metabolism. However, the degree to which this occurs under chemoprevention conditions would argue against the involvement of selenoproteins in the anticarcinogenic action of these selenium compounds.
1 This project was supported by grants CA 45164 and CA 27706 from the National Cancer Institute, NIH, and by the College of Agricultural and Life Sciences, University of Wisconsin, Madison, WI.
2 To whom requests for reprints should be addressed, at Department of Breast Surgery, Roswell Park Memorial Institute, 666 Elm Street, Buffalo, NY 14263.
Received 8/ 1/90. Accepted 10/24/90.
This article has been cited by other articles:
|
|
 |
|
  G.-x. Li, H.-J. Lee, Z. Wang, H. Hu, J. D. Liao, J. C. Watts, G. F. Combs Jr, and J. Lu Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite Carcinogenesis, May 1, 2008; 29(5): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Mousa, L. O'Connor, T. G. Rossman, and E. Block Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds Carcinogenesis, May 1, 2007; 28(5): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Park, A. Kim, J.-H. Oh, and A.-S. Chung Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-{kappa}B activation Carcinogenesis, April 1, 2007; 28(4): 837 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhao, F. E. Domann, and W. Zhong Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells Mol. Cancer Ther., December 1, 2006; 5(12): 3275 - 3284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Irons, B. A. Carlson, D. L. Hatfield, and C. D. Davis Both Selenoproteins and Low Molecular Weight Selenocompounds Reduce Colon Cancer Risk in Mice with Genetically Impaired Selenoprotein Expression J. Nutr., May 1, 2006; 136(5): 1311 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hu, C. Jiang, G. Li, and J. Lu PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells Carcinogenesis, August 1, 2005; 26(8): 1374 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, L. T. Glickman, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr, and J. S. Morris Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model Carcinogenesis, July 1, 2005; 26(7): 1256 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lyi, L. I. Heller, M. Rutzke, R. M. Welch, L. V. Kochian, and L. Li Molecular and Biochemical Characterization of the Selenocysteine Se-Methyltransferase Gene and Se-Methylselenocysteine Synthesis in Broccoli Plant Physiology, May 1, 2005; 138(1): 409 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Goulet, M. Chigbrow, P. Frisk, and M. A. Nelson Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells Carcinogenesis, January 1, 2005; 26(1): 109 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Marshall, M. Reid, and A. Duffield-Lillico RESPONSE: Re: Selenium Supplementation and Secondary Prevention of Nonmelanoma Skin Cancer in a Randomized Trial J Natl Cancer Inst, February 18, 2004; 96(4): 334 - 334. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhao, M. L. Whitfield, T. Xu, D. Botstein, and J. D. Brooks Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells Mol. Biol. Cell, February 1, 2004; 15(2): 506 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zu and C. Ip Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells Cancer Res., October 15, 2003; 63(20): 6988 - 6995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr., L. T. Glickman, C. Oteham, D. Schlittler, and J. S. Morris Effects of Dietary Selenium Supplementation on DNA Damage and Apoptosis in Canine Prostate J Natl Cancer Inst, February 5, 2003; 95(3): 237 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dong, H. Zhang, L. Hawthorn, H. E. Ganther, and C. Ip Delineation of the Molecular Basis for Selenium-induced Growth Arrest in Human Prostate Cancer Cells by Oligonucleotide Array Cancer Res., January 1, 2003; 63(1): 52 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jiang, Z. Wang, H. Ganther, and J. Lu Distinct Effects of Methylseleninic Acid versus Selenite on Apoptosis, Cell Cycle, and Protein Kinase Pathways in DU145 Human Prostate Cancer Cells Mol. Cancer Ther., October 1, 2002; 1(12): 1059 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dong, H. E. Ganther, C. Stewart, and C. Ip Identification of Molecular Targets Associated with Selenium-induced Growth Inhibition in Human Breast Cells Using cDNA Microarrays Cancer Res., February 1, 2002; 62(3): 708 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, C. Jiang, H. Ganther, and J. Lu Antimitogenic and Proapoptotic Activities of Methylseleninic Acid in Vascular Endothelial Cells and Associated Effects on PI3K-AKT, ERK, JNK and p38 MAPK Signaling Cancer Res., October 1, 2001; 61(19): 7171 - 7178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kim, U. Jung, D.-Y. Cho, and A.-S. Chung Se-Methylselenocysteine induces apoptosis through caspase activation in HL-60 cells Carcinogenesis, April 1, 2001; 22(4): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dong, D. Lisk, E. Block, and C. Ip Characterization of the Biological Activity of {{gamma}}-Glutamyl-Se- methylselenocysteine: A Novel, Naturally Occurring Anticancer Agent from Garlic Cancer Res., April 1, 2001; 61(7): 2923 - 2928. [Abstract] [Full Text]
|
|
|
|
|
|
C. Jiang, Z. Wang, H. Ganther, and J. Lu Caspases as Key Executors of Methyl Selenium-induced Apoptosis (Anoikis) of DU-145 Prostate Cancer Cells Cancer Res., April 1, 2001; 61(7): 3062 - 3070. [Abstract] [Full Text]
|
|
|
|
|
|
H. E. Ganther and C. Ip Thioredoxin Reductase Activity in Rat Liver Is Not Affected by Supranutritional Levels of Monomethylated Selenium In Vivo and Is Inhibited Only by High Levels of Selenium In Vitro J. Nutr., February 1, 2001; 131(2): 301 - 304. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Guzzo and M. S. Dubow A Novel Selenite- and Tellurite-Inducible Gene in Escherichia coli Appl. Envir. Microbiol., November 1, 2000; 66(11): 4972 - 4978. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Rooseboom, N. P. E. Vermeulen, I. Andreadou, and J. N. M. Commandeur Evaluation of the Kinetics of beta -Elimination Reactions of Selenocysteine Se-Conjugates in Human Renal Cytosol: Possible Implications for the Use as Kidney Selective Prodrugs J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 762 - 769. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ip, H. J. Thompson, Z. Zhu, and H. E. Ganther In Vitro and in Vivo Studies of Methylseleninic Acid: Evidence That a Monomethylated Selenium Metabolite Is Critical for Cancer Chemoprevention Cancer Res., June 1, 2000; 60(11): 2882 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ip, H. J. Thompson, and H. E. Ganther Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Normal and Premalignant Cells of the Rat Mammary Gland Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 49 - 54. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Janghorbani, Y. Xia, P. Ha, P. D. Whanger, J. A. Butler, J. W. Olesik, and L. Daniels Metabolism of Selenite in Men with Widely Varying Selenium Status J. Am. Coll. Nutr., October 1, 1999; 18(5): 462 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Ganther Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase Carcinogenesis, September 1, 1999; 20(9): 1657 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Finley The Retention and Distribution by Healthy Young Men of Stable Isotopes of Selenium Consumed as Selenite, Selenate or Hydroponically-Grown Broccoli Are Dependent on the Isotopic Form J. Nutr., April 1, 1999; 129(4): 865 - 871. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ip Lessons from Basic Research in Selenium and Cancer Prevention J. Nutr., November 1, 1998; 128(11): 1845 - 1854. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
